In particular, BC patients in the high-risk and low-risk groups showed differences in the levels of immune cell infiltrates, such as naïve B cells, plasma cells, CD8+T cells, Tregs, resting NK cells, and activated NK cells. The gene discussed is CD8A; the disease is breast cancer.